Exploring the link between Anti KU antibodies and Systemic Lupus Erythematosus
Anti KU Antibodies and Its Relationship With Systemic Lupus Erythematosus
This study is trying to see if there’s a connection between Anti KU antibodies and the symptoms of Systemic Lupus Erythematosus in patients who meet specific criteria.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 17 Years to 60 Years |
| Sex | All |
| Sponsor | Sohag University Academic / other |
| Locations | 1 site (Sohag) |
| Trial ID | NCT05900232 on ClinicalTrials.gov |
What this trial studies
This study investigates the relationship between Anti KU antibodies and the clinical manifestations of Systemic Lupus Erythematosus (SLE). It aims to determine how these antibodies correlate with the symptoms and severity of SLE in patients who meet the Systemic Lupus International Collaborating Clinics (SLICC) criteria. By analyzing patients who fulfill these criteria, the study seeks to enhance understanding of the autoimmune disorder and its underlying mechanisms.
Who should consider this trial
Good fit: Ideal candidates for this study are patients diagnosed with Systemic Lupus Erythematosus who meet the SLICC classification criteria.
Not a fit: Patients with other collagen diseases that are not Systemic Lupus Erythematosus will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic and therapeutic strategies for patients with Systemic Lupus Erythematosus.
How similar studies have performed: While the relationship between various antibodies and autoimmune disorders has been explored, this specific focus on Anti KU antibodies in SLE is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * all patients will fulfill the Systemic Lupus International Clinics(SLICC) classification criteria for Systemic Lupus Erythematosus. Exclusion Criteria: * any patient with any collagen disease other than SLE
Where this trial is running
Sohag
- Sohag University Hospitals — Sohag, Egypt (Recruiting)
Study contacts
- Study coordinator: Nehal A Ahmed, resident
- Email: nehal011209@med.sohag.edu.eg
- Phone: 01145379717
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.